Protocol Ledger

NCT06579573 · Phase III · RECRUITING

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

Interventional Phase III clinical trial protocol NCT06579573 sponsored by Ono Pharmaceutical Co in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-07-12 Enrollment: 15 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06579573
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)15 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06579573
Protocol FieldVerified Registry Value
NCT IdentifierNCT06579573
Consolidated Lead SponsorOno Pharmaceutical Co
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment15 participants (ESTIMATED)
Registered Start Date2022-07-12
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06579573
Hospital Research SiteLocationSite Profile
Kagoshima University HospitalKagoshima, JapanOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI